Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Presage Biosciences
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
DNAtrix, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins